首页> 外文OA文献 >Early detection of neuropathy in leprosy: A comparison of five tests for field settings
【2h】

Early detection of neuropathy in leprosy: A comparison of five tests for field settings

机译:麻风病神经病的早期发现:五个现场设置测试的比较

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

textabstractBackground: Early detection and treatment of neuropathy in leprosy is important to prevent disabilities. A recent study showed that the Nerve Conduction Studies (NCS) and Warm Detection Thresholds (WDT) tests can detect leprosy neuropathy the earliest. These two tests are not practical under field conditions, however, because they require climate-controlled rooms and highly trained staff and are expensive. We assessed the usefulness of alternative test methods and their sensitivity and specificity to detect neuropathy at an early stage. Methods: Through a literature search we identified five alternative devices that appeared user-friendly, more affordable, portable and/or battery-operated: the Neuropad®, Vibratip™, NC-Stat®DPNCheck™, NeuroQuick and the Thermal Sensibility Tester (TST), assessing respectively sweat function, vibration sensation, nerve conduction, cold sensation and warm sensation. In leprosy patients in Bangladesh, the posterior tibial and sural nerves that tested normal for the monofilament test and voluntary muscle test were assessed with the NCS and WDT as reference standard tests. The alternative devices were then tested on 94 nerves with abnormal WDT and/or NCS results and on 94 unaffected nerves. Sensitivity and specificity were the main outcomes. Results: The NeuroQuick and the TST showed very good sensitivity and specificity. On the sural nerve, the NeuroQuick had both a sensitivity and a specificity of 86%. The TST had a sensitivity of 83% and a specificity of 82%. Both the NC-Stat®DPNCheck™ and Vibratip™ had a high specificity (88% and 100%), but a low sensitivity (16% and 0%). On the posterior tibial nerve, the NeuroQuick and the TST also showed good sensitivity, but the sensitivity was lower than for the sural nerve. The Neuropad® had a sensitivity of 56% and a specificity of 61%. Conclusions: The NeuroQuick and TST are good candidates for further field-testing for reliability and reproducibility. The feasibility of production on a larger scale should be examined.
机译:textabstract背景:麻风病的早期发现和治疗对预防残疾很重要。最近的一项研究表明,神经传导研究(NCS)和温检测阈值(WDT)测试可以最早检测出麻风神经病。但是,这两个测试在野外条件下不可行,因为它们需要气候控制室和训练有素的工作人员,而且价格昂贵。我们评估了替代测试方法的有用性以及它们在早期检测神经病变的敏感性和特异性。方法:通过文献检索,我们发现了五种替代设备,它们看起来更人性化,更实惠,便携式和/或由电池供电:Neuropad®,Vibratip™,NC-Stat®DPNCheck™,NeuroQuick和热敏测试仪(TST ),分别评估出汗功能,振动感觉,神经传导,冷感觉和热感觉。在孟加拉国的麻风病患者中,以NCS和WDT作为参考标准测试评估了测试正常的单丝测试和自愿性肌肉测试的胫后神经和腓肠神经。然后,对具有WDT和/或NCS结果异常的94条神经以及94条未受影响的神经进行了测试。敏感性和特异性是主要结果。结果:NeuroQuick和TST显示出非常好的敏感性和特异性。在腓肠神经上,NeuroQuick的敏感性和特异性均为86%。 TST的敏感性为83%,特异性为82%。 NC-Stat®DPNCheck™和Vibratip™都具有较高的特异性(88%和100%),但灵敏度较低(16%和0%)。在胫后神经上,NeuroQuick和TST也显示出良好的敏感性,但敏感性低于腓肠神经。 Neuropad®的敏感性为56%,特异性为61%。结论:NeuroQuick和TST是进一步进行可靠性和可重复性现场测试的良好选择。应该检查大规模生产的可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号